Sage Therapeutics (SAGE) PT Lowered to $35 at RBC Capital

May 4, 2022 6:57 AM EDT
Get Alerts SAGE Hot Sheet
Price: $32.30 --0%

Rating Summary:
    14 Buy, 12 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 3 | Down: 10 | New: 9
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on Sage Therapeutics (NASDAQ: SAGE) to $35.00 (from $37.00) while maintaining a Sector Perform rating.

You May Also Be Interested In

Related Categories

Analyst PT Change